HEPHAISTOS-Pharma raised €4.3M in a Seed round in May 2024. The company is based in Orsay, France. Investors in the round: Elaia, Fondation Fournier-Majoie, Noshaq and 1 other. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €4.3M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
